Simethicone Capsule, Liquid Filled
NDC Package 73056-024-29

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Simethicone capsules is a medication used to relieve symptoms of extra gas caused by air swallowing or certain foods/infant formulas. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Bioventure Healthcare - Fze, this product is identified by NDC 73056-024.

Identification & Billing

NDC Package Code
73056-024-29
Package Description
29600 CAPSULE, LIQUID FILLED in 1 PACKAGE
Product Code
11-Digit Billing Format
73056002429

Clinical Specifications

Proprietary Name
Simethicone
Non-Proprietary Name
Simethicone
Substance Name
Dimethicone, Unspecified
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Active Ingredient(s)
Usage Information
This product is used to relieve symptoms of extra gas caused by air swallowing or certain foods/infant formulas. Simethicone helps break up gas bubbles in the gut.

Regulatory & Marketing

Labeler Name
Bioventure Healthcare - Fze
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
08-16-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73056-024-29 identifies a specific commercial package of 29600 capsule, liquid filled in 1 package of Simethicone (UNFINISHED drug), drug for further processing labeled by Bioventure Healthcare - Fze. This capsule, liquid filled is formulated for use and contains dimethicone, unspecified as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioventure Healthcare - Fze on August 16, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This product is used to relieve symptoms of extra gas caused by air swallowing or certain foods/infant formulas. Simethicone helps break up gas bubbles in the gut.

How is this Bioventure Healthcare - Fze product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73056002429. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73056-024-29
11-Digit CMS (5-4-2)
73056-0024-29

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.